Previous close | 41.30 |
Open | N/A |
Bid | 44.10 |
Ask | 47.90 |
Strike | 30.00 |
Expiry date | 2026-01-16 |
Day's range | 41.30 - 41.30 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately.
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.